Tender detail
Medicines
Summary
The tender concerns the supply of medicines containing dabigatran and the conclusion of a non-exclusive rebate agreement for the period 01/07/2026 to 30/06/2028, with a possible 1×12-month extension. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The machine-readable notice did not include precise participation or compliance requirements; these must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.